Azione 603567 HEILONGJIANG ZBD PHARMACEUTICAL CO., LTD.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Heilongjiang ZBD Pharmaceutical Co., Ltd.

Azioni

603567

CNE100002219

Prezzo di chiusura Shanghai S.E.
Altri mercati azionari
 00:00:00 30/04/2024 		Variaz. 5gg Var. 1 gen.
12,11 CNY +0,92% Grafico intraday di Heilongjiang ZBD Pharmaceutical Co., Ltd. +10,59% -0,41%
29/04 Heilongjiang ZBD Pharmaceutical Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024 CI
29/04 Heilongjiang ZBD Pharmaceutical Co., Ltd. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023 CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
ZBD Pharma Gets Nod for Tofacitinib Citrate Tablets
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
HeiLongJiang ZBD Pharma Registers Osteoarthritis Drug
Heilongjiang ZBD Pharmaceutical Co., Ltd.(XSSC:603567) added to S&P Global BMI Index
Heilongjiang ZBD Pharmaceutical Co., Ltd.(XSSC:603567) added to FTSE All-World Index
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Tranche Update on Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 10, 2022.
Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Equity Buyback announced on June 10, 2022 has closed with 2,560,300 shares, representing 0.27% for CNY 30 million.
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Tranche Update on Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 10, 2022.
Tranche Update on Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 10, 2022.
Heilongjiang ZBD Pharmaceutical to Tie Up With Kangyue Technology on Medicine Supplies
Heilongjiang ZBD Gets Approval for Traditional Medicine Product
Heilongjiang ZBD’s Anti-Pulmonary Fibrosis Drug Gets U.S. Patent
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Tranche Update on Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 10, 2022.
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione 603567
  4. Notizie Heilongjiang ZBD Pharmaceutical Co., Ltd.
  5. Altre lingue